These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10872678)

  • 21. Systemic B-cell chronic lymphocytic leukemia first presenting as a cutaneous infiltrate arising at the site of a herpes simplex scar.
    Kakagia D; Tamiolakis D; Lambropoulou M; Kakagia A; Grekou A; Papadopoulos N
    Minerva Stomatol; 2005 Mar; 54(3):161-3. PubMed ID: 15920448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual manifestations of B-cell disorders. Case 2: chronic lymphocytic leukemia presenting with cutaneous lesions.
    Schmid-Wendtner MH; Sander C; Volkenandt M; Wendtner CM
    J Clin Oncol; 1999 Mar; 17(3):1084-5. PubMed ID: 10071305
    [No Abstract]   [Full Text] [Related]  

  • 23. GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes.
    Yağci M; Akar I; Sucak GT; Haznedar R
    Leuk Res; 2005 Jul; 29(7):735-8. PubMed ID: 15927668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
    Cheung KJ; Tam W; Chuang E; Osborne MP
    Breast J; 2007; 13(4):413-7. PubMed ID: 17593048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
    Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.
    Rossmann ED; Lenkei R; Lundin J; Mellstedt H; Osterborg A
    Cytometry B Clin Cytom; 2007 Nov; 72(6):450-7. PubMed ID: 17565749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleural effusion of a second neoplasm in a patient with B-CLL: two immunological compartments.
    Atanackovic D; Brettner S; Hegewisch-Becker S
    Am J Hematol; 2003 Jul; 73(3):184-9. PubMed ID: 12827656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes.
    Golay J; Cittera E; Di Gaetano N; Manganini M; Mosca M; Nebuloni M; van Rooijen N; Vago L; Introna M
    Haematologica; 2006 Feb; 91(2):176-83. PubMed ID: 16461301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells.
    Mankaï A; Bordron A; Renaudineau Y; Martins-Carvalho C; Takahashi S; Ghedira I; Berthou C; Youinou P
    Cancer Res; 2008 Sep; 68(18):7512-9. PubMed ID: 18794139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of marginal zone lymphoma involving bone marrow.
    Kent SA; Variakojis D; Peterson LC
    Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
    Schröder C; Azimzadeh AM; Wu G; Price JO; Atkinson JB; Pierson RN
    Transpl Immunol; 2003; 12(1):19-28. PubMed ID: 14551029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD20 positive mycosis fungoides: a case report.
    Sen F; Kang S; Cangiarella J; Kamino H; Hymes K
    J Cutan Pathol; 2008 Apr; 35(4):398-403. PubMed ID: 18261116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemia cutis (involving chronic lymphocytic leukemia) within excisional specimens: a series of 6 cases.
    Walther BS; Gibbons G; Chan EF; Ziselman E; Rothfleisch JE; Willard RJ; Baldassano MF
    Am J Dermatopathol; 2009 Apr; 31(2):162-5. PubMed ID: 19318802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination of two forms of chronic leukemia and solid tumor in one patient].
    Tsyba NN; Obukhova TN; Kaplanskaia IB; Kovaleva LG; Tikhonova LIu; Gretsov EM; Misiurin AV
    Ter Arkh; 2007; 79(10):73-7. PubMed ID: 18154150
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples.
    Xu Y; McKenna RW; Asplund SL; Kroft SH
    Am J Clin Pathol; 2002 Nov; 118(5):758-64. PubMed ID: 12428797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.
    Spessotto P; Zucchetto A; Degan M; Wasserman B; Danussi C; Bomben R; Perris R; Canzonieri V; Radillo O; Colombatti A; Gattei V
    Matrix Biol; 2007 Jul; 26(6):473-84. PubMed ID: 17482449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic lymphocytic leukaemia involving the gallbladder.
    Chim CS; Loong F; Chung LP
    Br J Haematol; 2001 Dec; 115(4):717. PubMed ID: 11843800
    [No Abstract]   [Full Text] [Related]  

  • 40. The roles of lymph node stromal cells in proliferation of lymphoid leukaemia cells.
    Tsuda H; Nishimura H; Sawada T; Takatsuki K
    Br J Cancer; 1990 Mar; 61(3):362-4. PubMed ID: 2328199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.